In addition to IBI-10090, IBI-20089, IBI-60089, and IBI-80090, IBI is developing clinically superior products to treat a wide variety of ophthalmic diseases including, but not limited to, glaucoma, “wet” Age Related Macular Degeneration (“AMD”), diabetic macular edema, uveitis, cornea transplant rejection, and proliferative diabetic retinopathy.
My Canadian Pharmacy is an informative service. All the information should not be used in the purposes to establish a diagnosis and prescribe a treatment plan. Our company is a vendor, not a drug manufacturer. We cooperate with drug manufacturers who distribute their products to us. We have no relation with Icon Bioscience and Verisome. They move to another domain. We bear no responsibility for any damage brought to your health. All the questions related to the drug quality should be addressed to the drug manufacturer directly.